• Japanese
  • Korean
  • Traditional Chinese
  • Simplified Chinese
Home > Publishers > GBI Research
Publisher
Filter

GBI Research Report List

GBI Research publishes in-depth strategic intelligence reports in a broad range of professional industries, including, pharmaceuticals, medical devices, alternative energy, power, clean technology, oil and gas and chemicals. Their reports draw on in-depth primary and secondary research, proprietary databases and high quality analysis from their in house and external expert teams. Insights and analysis at the company, country and industry level includes competitor and market data, valuations, clinical & market trends, product pipelines and forecasts.

Filter
Title Search
1 - 25 of 511 Products Sort by Display
Diabetes & Obesity Drug Development Pipeline Review, 2016
Published by
GBI Research
Product code
397899
Published
December 1, 2016
Content info
560 Pages
Price
USD 3995
Sample available
Global Cancer Vaccines Market to 2022 - Robust Growth Driven by Increasing Prevalence, New Therapeutic Vaccine Approvals and Strong Uptake of Treatments Targeting CD19
Published by
GBI Research
Product code
399713
Published
November 1, 2016
Content info
183 Pages
Price
USD 4995
Sample available
Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation
Published by
GBI Research
Product code
399712
Published
November 1, 2016
Content info
61 Pages
Price
USD 6995
Sample available
Hemophilia A and B Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Increasing Treatment-Receiving Pool, Launch of Long-Acting Replacement Therapies and Non-factor Therapy
Published by
GBI Research
Product code
399711
Published
November 1, 2016
Content info
126 Pages
Price
USD 4995
Sample available
Ophthalmology Drug Development Pipeline Review, 2016
Published by
GBI Research
Product code
397898
Published
November 1, 2016
Content info
633 Pages
Price
USD 3995
Sample available
Global Cardiovascular Disease Market to 2022 - Sanofi and Novartis to Become Market Leaders as Praluent and Entresto Drive Revenue Growth
Published by
GBI Research
Product code
388271
Published
October 1, 2016
Content info
192 Pages
Price
USD 4995
Sample available
Global Gastrointestinal Drug Market to 2022 - Pipeline Characterized by Emerging Biologic Therapies, While TNF Inhibitors and PPIs Continue to Dominate Therapy Landscape
Published by
GBI Research
Product code
381440
Published
September 13, 2016
Content info
161 Pages
Price
USD 4995
Sample available
Frontier Pharma: Ophthalmology Therapeutics - Advancements in Disease Understanding Pave Way for Increasingly Diverse Therapeutic Options, with Age-Related Macular Degeneration and Glaucoma Leading the Way
Published by
GBI Research
Product code
388270
Published
September 1, 2016
Content info
70 Pages
Price
USD 6995
Sample available
Gastric Cancer Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Increasing Prevalence and Launch of Targeted Therapies
Published by
GBI Research
Product code
374467
Published
September 1, 2016
Content info
112 Pages
Price
USD 4995
Sample available
Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation
Published by
GBI Research
Product code
372574
Published
September 1, 2016
Content info
73 Pages
Price
USD 6995
Sample available
Type 2 Diabetes Mellitus Therapeutics in South-East Asia Markets to 2022 - Increasing Usage of Newer Therapies and Expanding Treatment Population to Encourage Robust Growth
Published by
GBI Research
Product code
369233
Published
August 1, 2016
Content info
176 Pages
Price
USD 4995
Sample available
Global Respiratory Drugs Market to 2022 - Pipeline and Market Characterized by Growing Prominence of Targeted Therapies, with Asthma and Cystic Fibrosis Leading the Way
Published by
GBI Research
Product code
369232
Published
August 1, 2016
Content info
202 Pages
Price
USD 4995
Sample available
Frontier Pharma: Chronic, Acute and Neuropathic Pain - GPCR and Nerve Growth Factor-based therapies offer strong potential in difficult-to-treat subtypes
Published by
GBI Research
Product code
369231
Published
August 1, 2016
Content info
68 Pages
Price
USD 6995
Sample available
Global Diabetes and Obesity Drugs Market to 2022 - Insulins and GPCRs Retain Commercial Prominence, While High Unmet Need Remains in Weight Loss Treatment
Published by
GBI Research
Product code
367993
Published
August 1, 2016
Content info
100 Pages
Price
USD 4995
Sample available
Frontier Pharma: Rheumatoid Arthritis - Cytokine Mediators and Kinase Inhibitors Dominate First-in-Class Product Innovation
Published by
GBI Research
Product code
367992
Published
August 1, 2016
Content info
66 Pages
Price
USD 6995
Sample available
Global Ophthalmology Drugs Market to 2022 - Angiogenesis Modulators and Gene Therapies to Boost Overall Revenue within the Forecast Period
Published by
GBI Research
Product code
367991
Published
August 1, 2016
Content info
150 Pages
Price
USD 4995
Sample available
Osteoporosis Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Rising Prevalence, Growing Awareness and Expected Launch of Anabolic Therapies
Published by
GBI Research
Product code
366603
Published
July 4, 2016
Content info
131 Pages
Price
USD 4995
Sample available
Global Urological Cancer Market to 2022 - Strong Growth Driven by Rising Prevalence, Increased Uptake of Hormone Therapies and Approval of Novel Biologics
Published by
GBI Research
Product code
363981
Published
June 16, 2016
Content info
143 Pages
Price
USD 4995
Sample available
Frontier Pharma: Diabetic Complications - Innovative and Diverse Neuropathies, Nephropathy and Retinopathies Pipelines Demonstrate Shift Towards Disease Modifying Therapies
Published by
GBI Research
Product code
363980
Published
June 1, 2016
Content info
73 Pages
Price
USD 6995
Sample available
Frontier Pharma: Hematological Cancers - Highly Innovative Pipeline Continues Trend towards Targeted, Patient-Specific Therapies
Published by
GBI Research
Product code
363067
Published
June 1, 2016
Content info
73 Pages
Price
USD 6995
Sample available
Non-Small Cell Lung Cancer Therapeutics in Asia-Pacific Markets to 2022 - Launch of Premium Targeted Therapies and Increasing Prevalence to Drive the Market
Published by
GBI Research
Product code
358649
Published
May 1, 2016
Content info
144 Pages
Price
USD 4995
Sample available
Global Dermatology Market to 2022 - Innovative Pipeline and Increasing Uptake of Biologics to Diversify Treatment Options and Drive Strong Growth
Published by
GBI Research
Product code
358647
Published
May 1, 2016
Content info
144 Pages
Price
USD 4995
Sample available
Global Hematological Cancers Market to 2022 - Commercially Successful Targeted Therapies and Large, Innovative Pipeline to Drive Market
Published by
GBI Research
Product code
358648
Published
April 21, 2016
Content info
147 Pages
Price
USD 4995
Sample available
Global Viral Infections Market to 2021 - Promising New Competitors and Expanding Treatment Population to Offset Increased Uptake of Generics
Published by
GBI Research
Product code
357639
Published
April 5, 2016
Content info
179 Pages
Price
USD 4995
Sample available
Global Non-Hematological Cancers Market to 2021 - Strong growth driven by increased uptake of low toxicity targeted treatments and versatile biologics
Published by
GBI Research
Product code
357638
Published
April 1, 2016
Content info
183 Pages
Price
USD 4995
Sample available